Ledger.Open graph →
SEC Form D · filed June 20, 2016

Blade Therapeutics, Inc

Offering
$45.4M
Sold
$27.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Peter Van Vlasselaer · SOUTH SAN FRANCISCO, CADirectorWendye Robbins · Seattle, WAExec · DirectorWilliam Slattery · SOUTH SAN FRANCISCO, CADirectorLuke Evnin · Boston, MADirectorCameron Wheeler · Seattle, WADirectorElaine Jones · Richmond, British Columbia, CanadaDirectorJames Scopa · SAN DIEGO, CADirectorLuke Evnin · Boston, MADirectorCameron Wheeler · Seattle, WADirectorPeter Van Vlasselaer · SOUTH SAN FRANCISCO, CADirectorElaine Jones · Austin, TXDirectorWendye Robbins · San Francisco, CAExec · DirectorWilliam Slattery · SOUTH SAN FRANCISCO, CADirectorJames Scopa · SOUTH SAN FRANCISCO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗